OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose
Bruno Andraus Filardi, Valter Silva Monteiro, Pedro Vellosa Schwartzmann, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 683
Open Access | Times Cited: 12
Bruno Andraus Filardi, Valter Silva Monteiro, Pedro Vellosa Schwartzmann, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 683
Open Access | Times Cited: 12
Showing 12 citing articles:
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 743
Open Access | Times Cited: 10
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 743
Open Access | Times Cited: 10
Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort
Liam Townsend, Louise Marron, Katie M. O’Brien, et al.
QJM (2024) Vol. 117, Iss. 9, pp. 638-646
Closed Access | Times Cited: 4
Liam Townsend, Louise Marron, Katie M. O’Brien, et al.
QJM (2024) Vol. 117, Iss. 9, pp. 638-646
Closed Access | Times Cited: 4
The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
Xiu Hong Yang, Wen Jing Bao, Hua Zhang, et al.
Journal of General Internal Medicine (2023)
Open Access | Times Cited: 11
Xiu Hong Yang, Wen Jing Bao, Hua Zhang, et al.
Journal of General Internal Medicine (2023)
Open Access | Times Cited: 11
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial
Xiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102231-102231
Open Access | Times Cited: 7
Xiaoqiang Liu, Zhonghan Sun, Zhongfang Wang, et al.
EClinicalMedicine (2023) Vol. 64, pp. 102231-102231
Open Access | Times Cited: 7
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
Xiaolan Yong, Jun Liu, Ying Zeng, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 6
Xiaolan Yong, Jun Liu, Ying Zeng, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 6
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariant BA.5 after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Keita Kawashiro, Rigel Suzuki, Takuto Nogimori, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Keita Kawashiro, Rigel Suzuki, Takuto Nogimori, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
Marcelo Wolff, Paulo Charpentier, Andrea Canals, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 671-676
Open Access | Times Cited: 3
Marcelo Wolff, Paulo Charpentier, Andrea Canals, et al.
Vaccine (2023) Vol. 42, Iss. 3, pp. 671-676
Open Access | Times Cited: 3
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 2
Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients
Keita Kawashiro, Rigel Suzuki, Takuto Nogimori, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Keita Kawashiro, Rigel Suzuki, Takuto Nogimori, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
Xiaolan Yong, Jun Liu, Ying Zeng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Xiaolan Yong, Jun Liu, Ying Zeng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines
Serkan Atıcı, Ahmet Soysal, Erdem Gönüllü, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2023) Vol. 56
Open Access
Serkan Atıcı, Ahmet Soysal, Erdem Gönüllü, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2023) Vol. 56
Open Access
